Mandate

Vinge advises in conjunction with the sale of Astrego Diagnostics to Sysmex

May 02, 2022 M&A

Vinge has advised the main owners of Astrego Diagnostics AB in conjunction with the sale of the shares to the Japanese minority owner, Sysmex Corporation.

Astrego has developed a diagnostic tool for determining the presence of bacteria in patient samples and the determination of resistance against different antibiotics (so-called ”Antibiotic Susceptibility Test, AST”).

Vinge’s team consisted of Johan Winnerblad, Eléonore Friberg, Viktoria Owetz Leyva and Gunilla Nyman.

Related

Vinge has advised Rite Ventures in connection with sale of shares in Qliro AB (publ)

Vinge has advised Rite Ventures in connection with the sale of shares in Qliro AB (publ) to Svea Bank AB (publ).
November 19, 2026

Vinge advises Röko AB (publ) in connection with the establishment of its MTN programme

Vinge has advised Röko AB (publ) ("Röko") on the establishment of a medium-term note programme (the "MTN Programme") with a framework amount of SEK 5 billion.
November 13, 2026

Vinge advises Telavox on the sale of its Nordic customer base to Telia

Vinge has advised Telavox AB (“Telavox”) on the sale of Telavox’s Nordic customer base for business services to Telia Company AB (“Telia”). The customer base comprises approximately 24,000 business customers and 325,000 end users in Sweden, Denmark, Finland, and Norway. The purchase price amounts to SEK 3.8 billion plus a potential additional earn-out.
November 13, 2026